Stay updated on ICT-107 Immunotherapy in GBM Clinical Trial
Sign up to get notified when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.

Latest updates to the ICT-107 Immunotherapy in GBM Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision is updated from v3.4.3 to v3.5.0, reflecting a minor version update.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.4.2 was added. The older Revision: v3.4.1 notice and the funding-status alert were removed.SummaryDifference0.4%

- Check70 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check77 days agoChange DetectedA new data field 'Last Update Submitted that Met QC Criteria' was added to the study record, and the page revision is shown as v3.4.0. The page also adds a 'Show glossary' option and makes minor capitalization adjustments for FEAR Act data and QC-related labels.SummaryDifference0.2%

- Check91 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

Stay in the know with updates to ICT-107 Immunotherapy in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.